To assess the clinical relevance of the above genes, we analyzed the overall survival (OS) and disease-free survival (DFS) of patients with ACC in TCGA cohort (N=79) using mRNA expression of genes in the HSP90 and PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and adrenal cortex carcinoma.